LFTD Partners Inc.

LIFD ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item Jun 2026 Mar 2026 Dec 2025 Sep 2025 Jun 2025 Mar 2025 Dec 2024 Sep 2024
Operating Activities
Net Income $-1.4M $-4.2M $-24.9M $634.3K $-269.0K $-303.0K $1.2K $-194.4K
Depreciation & Amortization $47.0K $139.3K $288.6K $62.2K $62.5K $139.6K $287.3K $58.1K
Depreciation — — — — $76.6K — — —
Amortization — — — — — — — —
Stock-Based Compensation — — — — — — — —
Net Cash from Operating Activities $-554.9K $458.9K $536.3K $699.0K $-265.6K $351.8K $-892.9K $-312.1K
Investing Activities
Capital Expenditures $19.3K $119.7K $34.6K $2.5K $7.4K $77.1K $3.0K $22.2K
Business Acquisitions — — — — — — — —
Net Cash from Investing Activities $-19.3K $-119.7K $-34.6K $-2.5K $-7.4K $-77.1K $1.0K $8.0K
Financing Activities
Dividends Paid — — — — — — — —
Stock Repurchases — — — — — — — —
Net Cash from Financing Activities $-12.6K $-15.2K $-1.7M $-891.9K $109.1K $-141.6K $-136.0K $-134.9K
Net Change in Cash — — — — — — — —
Free Cash Flow $-574.3K $339.2K $501.8K $696.5K $-273.0K $274.6K $-895.9K $-334.3K
← Newer Page 1 of 8 Older →